| |
 |
MILLENNIUM BIOTECHNOLOGIES GROUP INC. (OTCBB: MBTG)
|
 |
Dear Reader,
The beverage market is liquid to say the least, and in the highly scrutinized arena of sports drinks and recovery beverages, enhancements matter most. Science-driven innovation in the sports drink industry, vetted on the playing field as well as in the laboratory, can lead to enormous success in the consumer market if positioned properly.
Perhaps this opens the door for Millennium Biotechnologies, Inc. (OTCBB: MBTG), which recently announced preliminary results of its second double-blind, placebo-controlled clinical trial that found its Resurgex® nutritional formula provided improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat in Rutgers University Division 1 football players (strength athletes). The preliminary results showed Resurgex® outperformed a leading sports nutritional formula commonly used by athletes.
Please take a moment to learn about this exciting and innovative company
that is a pioneer in the emerging field of specialized nutritional supplements
 |
About Millennium Biotechnologies |
 |
Millennium Biotechnologies, Inc., ("Millennium""MBTG") is a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. MBTG is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements. MBTG's flagship products include: RESURGEX®, RESURGEX Plus™, and RESURGEX Select™.
.
The Resurgex® family of products was designed to provide sophisticated nutritional support for immuno-compromised individuals as well as elite-level athletes.
In stark contrast to the nutritional products available in the medical market today, the Resurgex formulas combine healthy, whole food calories along with a proprietary blend of supportive micro-nutrients. Addressing the nutritional needs of individuals undergoing medical treatment for such conditions as HIV/AIDS, hepatitis and cancer, Millennium’s line of nutraceuticals support healthy weight, lean muscle, reduced oxidative stress and increased energy production. RESURGEX®, RESURGEX Plus™, and RESURGEX Select™ are proudly recommended and prescribed at a great number of high profile medical institutions nationwide.
Born from its success in the medical market, Resurgex nutritionals also play important supportive roles in the recovery of professional and amateur level athletes. Resurgex products for athletes combine unparalleled clinical support for its capacity to aid the athlete's ability to recover quicker so as to perform at a higher level. The variation in caloric levels, all while providing the same advanced micro-nutrient profile, makes the Resurgex line ideal for the endurance as well as strength athlete.
Convenient dosing formats, premier flavor systems, third party insurance coverage and multiple distribution outlets helps to increase adherence and availability of the Resurgex line amongst its users. Millennium plans to continue building its product line in its quest to provide optimal and proprietary nutritional support for the medical as well as the athletic communities.
Millennium is currently in the process of redesigning and restructuring the company to better suit its two primary core competencies of identified care for athletes and cancer patients. Millennium plans to file with the Securities and Exchange Commission and mail to its stockholders a proxy statement which will contain information about Millennium, the sale of its assets and the formation and capitalization of RAC Nutrition (the "Proposed Transaction") and related matters.
 |
The Resurgex Advantage |
 |
What Makes It Unique? It’s Patented (U.S.Patent #6,503,506 - January 7, 2003)
Use and Composition Patent
Nutrient Therapy for Immuno-Compromised Conditions
BRIEF DESCRIPTION OF THE INVENTION - The present t nutritional support composition addresses the needs of those whose immune systems are compromised through chronic debilitating diseases through a multiprong approach designed to:
- Decrease oxidation stress
- Help restore lean muscle mass
- Up-regulate/increase energy production (decrease mitochondrial failure)
- Support Immune System
Resurgex Credentials
Received a National Drug Code
Received Federal HCPCS Codes: B-4155 Resurgex, B-4152 for Resurgex Plus and Resurgex Select
Resurgex, Resurgex Plus and Resurgex Select are Registered Trademarks
Received a US Patent for the Composition and Use of Resurgex® Patent No. 6,503,506 (Resurgex Plus is patent pending)
Patent Pending in 57 Countries Worldwide
Received Medicaid Approval in the following states: New York, New Jersey, Pennsylvania, Connecticut, Nevada, Michigan, Florida
Received ADAP Approval in New York
Received Special Pharmaceutical Benefits Program Approval in Pennsylvania
Resurgex® has been dispensed in over 315 different pharmacies in 7 different States
Resurgex® is available through every major national and regional pharmaceutical wholesaler including: Kinray, Cardinal, Amerisource-Bergen, McKesson, Bellco, and Rochester Drug
Resurgex® is prescribed in many prestigious medical institutions including: Montefiore, North Central Bronx, Bronx Lebanon, Harlem Hospital, St. Barnabas, Westchester Medical, St. Vincents, St. Vincents Midtown, Brookdale, Lenox Hill, Mt. Vernon, Beth Israel, Mt. Sinai - MD Anderson, City Of Hope, Cleveland Clinic, Johns Hopkins, NYU Medical, Sammons Cancer Center, Northwestern Medical Center, University of Illinois Chicago, Fox Chase Cancer Center - and many more.
 |
Resurgex® Provides Strength And Body Composition Benefits To Athletes: The Rutgers Studies |
 |
Resurgex® Provides Strength And Body Composition Benefits To Athletes
Millennium Biotechnologies, Inc. recently announced preliminary results of its second double blind, placebo controlled clinical trial that found its Resurgex® nutritional formula provided improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat in Rutgers University Division 1 football players (strength athletes). The preliminary results showed Resurgex® out performed a leading sports nutritional formula commonly used by athletes. This emerging new data, coupled with the first trial that found its Resurgex® nutritional formula provided enhanced performance parameters and reduced oxidative stress levels (free radical damage caused by exercise) in Rutgers University Division 1 soccer players (endurance athletes), further suggests an important role for Resurgex in the sports fitness field. - BioSpace.com 8/22/06
The Studies
NUTRITIONAL SUPPLEMENTATION (RESURGEX) IN MALE COLLEGE SOCCER PLAYERS:
EFFECTS ON PERFORMANCE AND OXIDATIVE STRESS
Shawn M. Arent, PhD, CSCS, David DiFabio, CSCS, John Greenwood, Joseph Pellegrino, Carey A. Williams, PhD. Human Performance Lab, Rutgers University, New Brunswick, NJ.
-------------------------------------------
Double Blind, Placebo Controlled Study
Improved Performance: There were significant changes in performance capacity and reduced oxidative stress in the Resurgex group as compared to the Control group (Boost)
Improved Lactic Acid Response: The Resurgex group had improved lactic acid responses to exercise and time to exhaustion as compared to the controls
Reduced Oxidative Stress: The Resurgex group had a significantly lower oxidative stress markers isoprostanes and (LPO’s) compared to control
NUTRITIONAL SUPPLEMENTATION (RESURGEX) IN MALE COLLEGE FOOTBALL PLAYERS:
EFFECTS ON STRENGTH, BODY COMPOSITION AND OXIDATIVE STRESS
Shawn M. Arent, PhD, Human Performance Lab, Rutgers University, New Brunswick, NJ.
-------------------------------------------
Double Blind, Placebo Controlled Study
Improved Body Composition: while both groups gained weight, the Resurgex (experimental) group gained muscle and lost a slight amount of body fat while the Gatorade Performance Shake (control) group gained ½ of their weight as body fat
Improved Power/Strength: using Wingate Testing, Peak power was measured for each test and standardized by body weight. The increase in peak power in the Resurgex group was approximately 86% greater than the increase in the Gatorade Performance Shake group.
Improved Recovery Parameters: the Resurgex group had a significant improvement in their testosterone:cortisol ratio while the Gatorade Performance Shake group had a decrease in this ratio.
*Going Beyond Sugar & Stimulants*
International Olympic Committee (IOC)
Compliant
National Collegiate Athletic Association (NCAA)
Compliant
-Does Not Contain Any Banned or Non-Permissible Substances-
>a
 |
Marketing MBTG Products |
 |
It is difficult, but maintaining a well-balanced diet helps protect healthy cells against the toxic effects of chemotherapy and radiation, thus making the cancer cells more vulnerable to the medicine. Healthy calories are essential for maintaining weight. Adequate protein will help to optimize the immune system, strength, and tolerance to treatments. That means eliminating from a person's diet refined white flour, refined white sugar, milled grains, and ingredients like high-fructose corn syrup and choosing quality carbohydrates, complete proteins, good fats, and lots of fruits and vegetables.
Quality Carbohydrates
Carbohydrates come in two basic forms: complex and simple. Simple carbohydrates are one, two, or at most three units of sugar linked together in single molecules. Complex carbohydrates are hundreds or thousands of sugar units linked together in single molecules. Simple sugars are easily identified by their taste: sweet. Complex carbohydrates, such as whole grains, are pleasant to the taste buds, but not sweet. High-fiber grains like oats, barley and brown rice are the best sources for complex carbohydrates.
Complete Proteins
Whey protein has long been considered the best source of protein for building and retaining lean muscle mass. Additionally, undenatured whey has been shown to assist in cellular defenses by increasing available glutathione. Whey is a complete protein, which contains all the essential and non-essential amino acids, and boasts the highest branched chain amino acid content found in nature.
Good Fats
Omega-3 fatty acids, a form of polyunsaturated fat, are essential to overall health and rehabilitation as the body relies on dietary sources to attain. Specifically, the omega-3 fat called DHA is critical for brain, heart and immune health. Cold-water fish such as salmon, herring, mackerel, halibut and tuna contain oils rich in omega-3 fatty acids.
Other polyunsaturated fats that can help keep you healthier are found in flax oil, safflower oil, sunflower oil and other vegetable derived oils. Since most fats consume a lot of energy to metabolize, special structured fats called MCTs (medium chain triglycerides) are easier to digest than other fats.
Fruits and Vegetables
Fruits and vegetables are valuable to your overall health. They contain important compounds and are essential for your immune system and the health of the entire body. Studies also show a relationship between eating particular types of produce and a reduced risk of cancer. Focus on foods rich in botanical factors or phytonutrients including berries, dark green leafy vegetables, citrus fruits, legumes (beans of all sorts including soy) and whole grains.
a
 |
MBTG Products |
 |
Resurgex Select
Resurgex Select offers nutrition specially designed for patients undergoing active treatment. During treatment for cancer, proper nutrition can help you feel stronger and more energetic. Resurgex Select is designed to help you get the calories and nutrients you need.
A good source of energy during treatment
Resurgex Select offers a healthy combination of high quality protein, complex carbohydrates, MCTs, and omega 3 DHA to give your body the fuel it needs to stay strong. In addition, a multipart fruit and vegetable extract and FOS help maintain GI health.

Resurgex Plus
A Complex Fuel for Growth
Resurgex Plus adds high quality protein, complex carbohydrates from whole grains, vitamins, antioxidants, and amino acids your body needs to support healthy body weight.
A Good Source of Energy
The nutrients, whey protein, complex carbohydrates, and essential fats in Resurgex Plus can help you generate energy naturally and assist in healthy cell development.
A Unique Formulation of Antioxidants
In addition to being rich in vitamins C and E, zinc, and selenium, Resurgex Plus contains GliSODin® (vegetarian superoxide dismutase).
Resurgex
Going Beyond Sugar and Fat
Rich in vitamins, antioxidants, and amino acids, Resurgex contains the nutrition necessary to support healthy body weight.
In addition to being rich in vitamins C and E, zinc, and selenium, Resurgex contains GliSODin® (vegetarian superoxide dismutase).
Flavor choices to fit individual tastes: Available in 2 delicious flavors – Vanilla Supreme and Apple Blast
– which can each be mixed with water, milk, or juices for variety.
For more information on cancer and nutrition
navigate to the links below
 
a
 |
Recent News From Millennium |
 |
Press Release Source: Millennium Biotechnologies Group
Tuesday November 7, 12:42 pm ET
Former Senior Vice President of NBA Entertainment
Joins the Resurgex Sports Marketing Team
BASKING RIDGE, N.J., Nov. 7, 2006 (PRIMEZONE) -- Millennium Biotechnologies (OTC BB:MBTG.OB - News), manufacturer of Resurgex, a popular line of nutritional supplements, announced the appointment of Don Sperling, former Senior Vice President of NBA Entertainment to the Company's sports marketing team.
The Resurgex line had primarily been used to relieve fatigue commonly found in those with deficiencies of the immune system. In 2005, Millennium Biotechnologies began supplying professional sporting organizations with Resurgex to increase recovery and to improve performance in athletes undergoing rigorous training. The appointment of Mr. Sperling is indication of the company's continuing focus on becoming one of the leading suppliers of specialized nutritional supplements to professional and collegiate athletes.
Mr. Sperling brings to Millennium Biotechnologies over 20 years of sports marketing and television media production experience. During Mr. Sperling's fifteen year tenure as Senior Vice President and Executive Producer of NBA Entertainment, NBA TV and NBA.com, the NBA became the largest producer and broadcaster of sports programming and digital media with over 240 affiliates worldwide.
"Don's background is perfectly suited to design targeted marketing strategies appropriate for the launch of our line of sports products," said Jerry Swon, President and CEO of Millennium Biotechnologies. "Don is the perfect leader to help us build off of our current success."
Not only was Don the creator of "NBA Inside Stuff," ABC's longest running weekly sports and entertainment show, but in 1997 he was one of the leading forces behind the launch of the Women's National Basketball Association (WNBA), earning Don and his team the coveted "Sports Marketer of the Year" award.
"This cutting edge product is in the right place at the right time," said Don Sperling. ``Resurgex has clinically proven benefits that will help all athletes perform at peak levels longer and decrease recovery time from modern day training regimens."
To read the complete release and disclaimer, Click Here
Press Release Source: Millennium Biotechnologies Group
Wednesday October 25, 11:31 am ET
Millennium Biotechnologies Group Enters Into Asset Purchase Agreement With Aisling Capital to Exchange Nutraceutical Business for Equity in Newly Formed Company
BASKING RIDGE, N.J., Oct. 25, 2006 (PRIMEZONE) -- Millennium Biotechnologies Group, Inc. (OTC BB:MBTG.OB - News) announced today that it has entered into an Asset Purchase Agreement with RAC Nutrition Corporation, a newly formed company controlled by Aisling Capital II, LP in accordance with the previously announced letter of intent. Pursuant to the Asset Purchase Agreement, Millennium will exchange all of the assets used in Millennium's nutraceutical business to RAC Nutrition for shares of common stock of RAC Nutrition. The newly formed RAC Nutrition will be initially capitalized by the issuance to Aisling and other investors of $15 million in convertible preferred stock. The Asset Purchase Agreement, which has been filed as an exhibit to Millennium's Current Report on Form 8-K, is subject to various conditions, including approval by Millennium's stockholders. Aisling Capital II, LP is a leading private equity fund that invests in life science companies developing biopharmaceutical products and creating businesses based on advanced life sciences technology.
To read the complete release and disclaimer, Click Here
Press Release Source: Millennium Biotechnologies, Inc.
Thursday August 31, 9:15 am ET
Millennium Biotechnologies' Announces Initial Sales and Distribution
to Professional Sports Teams
With 2 Double Blind, Placebo Controlled Clinical Trials Directed at Strength and Endurance Athletes, Resurgex(R) Begins to Make Its Mark in the Sports Marketplace
BASKING RIDGE, N.J.--(BUSINESS WIRE)--Aug. 31, 2006--Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTCBB:MBTG - News), a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements for the medical market, today announced initial distribution and sales of its Resurgex® products in the professional and collegiate sport marketplaces. With Resurgex® outperforming leading nutritional formulas in 2 double blind, placebo controlled trials conducted in both strength and endurance athletes, the important role for Resurgex® in the sports medicine and fitness field is being unanimously accepted. In strength athletes, the benefits associated with Resurgex® demonstrated improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat as compared to a leading sports nutritional formula. In endurance athletes, Resurgex® was shown to provide enhanced performance parameters and reduced oxidative stress levels (free radical damage caused by exercise).
"We are very excited about the opportunities for Resurgex in professional sports. Unfortunately, the sports marketplace has been dominated by products that contain artificial stimulants, steroid precursors or excessive amounts of protein. In addition, the marketplace is rampant with products with unsubstantiated claims. Resurgex products finally represent well thought out, medically accepted and scientifically substantiated formulas that address the very nutritional needs of athletes similar to those shared by the chronically ill patient." said Carl Germano, RD, CNS, CDN, Senior Vice President of Product Development and Research for Millennium Biotechnologies. "With more then 5 years acceptance and success in the medical marketplace and scientific substantiation demonstrating performance and strength benefits in athletes, Resurgex® represents one of the most credible nutritional formulas to come to the sports market in decades."
To read the complete release and disclaimer, Click Here
Source: Millennium Biotechnologies Group, Inc.
Aug 22, 2006
Millennium Biotechnologies' Resurgex(R) Provides Strength and
Body Composition Benefits to Athletes
Preliminary Results of a Double Blind, Placebo Controlled Clinical Trial Finds Resurgex(R) Group Out Performs Leading Sport Nutritional
BASKING RIDGE, N.J., Aug 22, 2006 (BUSINESS WIRE) -- Millennium Biotechnologies, Inc. (OTCBB:MBTG), a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements for the medical market, today announced preliminary results of its second double blind, placebo controlled clinical trial that found its Resurgex(R) nutritional formula provided improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat in Rutgers University Division 1 football players (strength athletes). The preliminary results showed Resurgex(R) out performed a leading sports nutritional formula commonly used by athletes. This emerging new data, coupled with the first trial that found its Resurgex(R) nutritional formula provided enhanced performance parameters and reduced oxidative stress levels (free radical damage caused by exercise) in Rutgers University Division 1 soccer players (endurance athletes), further suggests an important role for Resurgex in the sports fitness field.
"While this human trial further validates the efficacy of Resurgex(R) during strenuous activity, we are very excited about these initial results which reinforce the functionality of our product now in the strength athlete," said Carl Germano, RD, CNS, CDN, senior vice president of product development and research for Millennium Biotechnologies. "These preliminary findings provide further confirmation of the importance of Resurgex to address the true nutritional needs of the athlete. We have focused on assisting the athlete's recovery that enables for better performance. While our first trial demonstrated the ability for Resurgex to improve performance while lowering oxidative stress, this study is pointing to the ability of Resurgex to improve strength parameters, increasing muscle gain while reducing body fat."
To read the complete release and disclaimer, Click Here
a
 |
**Please Note** |
 |
MILLENNIUM PRODUCTS ARE SUBJECT TO SIGNIFICANT GOVERNMENT REGULATION
The packaging, labeling, advertising, promotion, distribution and sale of RESURGEX(R), RESURGEX Plus(TM) and RESURGEX SELECT(TM) and other products we
plan to produce and market are subject to regulation by numerous governmental agencies, the most active of which is the U.S. Food and Drug Administration (the
"FDA"), which regulates our products under the Federal Food, Drug and Cosmetic Act (the "FDCA") and regulations promulgated thereunder. Our products are also
subject to regulation by, among other regulatory entities, the Consumer Product Safety Commission (the "CPSC"), the U.S. Department of Agriculture (the "USDA")
and the Environmental Protection Agency (the "EPA"). Advertising and other forms of promotion and methods of marketing of our products are subject to regulation
by the U.S. Federal Trade Commission (the "FTC"), which regulates these activities under the Federal Trade Commission Act (the "FTCA"). The manufacture,
labeling and advertising of our products are also regulated by various state and local agencies. Failure to comply with applicable regulatory requirements may
result in, among other things, injunctions, product withdrawals, recalls, product seizures, and fines.
a
 |
Financial Highlights For MBTG |
 |

Inventories at June 30, 2006
Samples: 186,766
Finished Goods: 554,854
Total revenues generated from the sales of RESURGEX(r), RESURGEX PLUS(tm) and RESURGEX SELELCT(tm) for the quarter ended June 30, 2006 were $200,898 an increase of approximately 26% from the second quarter in 2005, which had total revenues of $159,169.
MILLENNIUM is a fully reporting company, to view the latest filings at the SEC Web site, Click Here
Last Trade: 0.22 (11-28-06)
52wk Range: 0.16 - 0.52
Avg Vol (3m): 90,442
Market Cap: 15.1M
Sector: Healthcare
Industry: Biotechnology
State of Incorporation: Delaware
Fiscal Year Ends: 31-Dec
Revenue (ttm): 766.79K
Shares Outstanding: 67.96M
Float: 55.03M
Transfer Agent:
American Stock Transfer
CIK: 0000072170
Shareholders of Record:
534 as of 2006-04-17 |
 |
aa
 |
TO CONTACT MILLENNIUM |
 |
Millennium Biotechnologies, Inc.
665 Martinsville Road, Suite 219
Basking Ridge, New Jersey 07920
Frank Guarino (908) 604-2500 or toll free (888) 412-9179
or to send an e-mail to Frank, Click Here
To Order, Call : 1-877-RESURGX (737-8749)
RESURGEX WEB SITE
CLICK HERE
*** The Bull is Running. ***
There may never be a better time to feature YOUR company
to over 1 MILLION investors.
To learn more about our programs email us directly at info@stockupticks.com
Stockupticks Safe Harbor Statement: Statements contained in this document, including those pertaining to estimates and related plans, potential mergers and acquisitions, estimates, growth, establishing new markets, expansion into new markets and related plans other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made. StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP). MP provides no assurance as to the subject company's plans or ability to effect any planned and/or proposed actions. MP has no first-hand knowledge of management and therefore cannot comment on its capabilities, intent, resources, nor experience and makes no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources believed by MP to be reliable, but MP provides no assurance, and none is given, as to the accuracy and completeness of this information.
Disclaimer: StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP). The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. Past performance is no guarantee of future results. This report is a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP has been paid twenty four thousand dollars by Millennium Biotechnologies, Inc. for preparation and distribution of this report and other advertising services over a ninety day period. This constitutes a conflict of interest as to MP’s ability to remain objective in its communication regarding the subject company. Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934 - Market Pathways 17595 Harvard Ave., Suite C519 Irvine, CA 92614. MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities but is a paid advertisement. Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results. The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned. Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated. |
|